InfuSystem Holdings, Inc. (INFU)
| Market Cap | 345.24M |
| Revenue (ttm) | 94.39M |
| Net Income (ttm) | 7.47M |
| Shares Out | 20.18M |
| EPS (ttm) | 0.35 |
| PE Ratio | 49.02 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 26 |
| Last Price | $17.06 |
| Previous Close | $17.71 |
| Change ($) | -0.65 |
| Change (%) | -3.67% |
| Day's Open | 17.75 |
| Day's Range | 16.93 - 17.95 |
| Day's Volume | 90,342 |
| 52-Week Range | 5.26 - 20.17 |
RODCHESTER HILLS, Michigan, Feb. 11, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, ...
Rochester Hills, Michigan, Feb. 03, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, ...
Growth-focused investors may be interested in the following small-cap stocks, as they represent companies whose trailing 12-month earnings per share improved significantly on a year-over-year ...
InfuSystem is uniquely positioned to benefit from any resurgence in COVID-19, and ex-COVID has strength in the core business model. Shareholders have enjoyed ~120% upside YTD, and shares have ...
Revenues of $107 million - $110 million; Adjusted EBITDA of $29 million - $30 million; Operating Cash Flow of $21 million - $23 million; Revenues of $107 million - $110 million; Adjusted EBITD...
Rochester Hills, Michigan, Dec. 14, 2020 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, f...
Conference Call to be held 9:00 a.m. Eastern Time Conference Call to be held 9:00 a.m. Eastern Time
ROCHESTER HILLS, Michigan, Nov. 16, 2020 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provider, ...
InfuSystem Holdings Inc. (INFU) CEO Rich Dilorio on Q3 2020 Results - Earnings Call Transcript
Revenue: $25.1 million, a 17% increase vs. Prior Year Net Income: $2.9 million, an increase of 159%, and Adjusted EBITDA: $7.5 million, a 46% increase
Investor Conference Call to be held 9:00 a.m. Eastern Time Investor Conference Call to be held 9:00 a.m. Eastern Time
Investor Presentation to be held 3:15 p.m. Eastern Time Investor Presentation to be held 3:15 p.m. Eastern Time
ROCHESTER HILLS, Michigan, Sept. 09, 2020 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provide...
InfuSystems (NYSE: INFU) shares are trading higher on Monday after Craig-Hallum initiated coverage on the stock with a Buy rating and a price target of $28 per share.
Rochester Hills, Michigan, Aug. 25, 2020 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provider...
InfuSystem Holdings Inc. (INFU) CEO Rich Dilorio on Q2 2020 Results - Earnings Call Transcript
Investor Conference Call to be held 9:00 a.m. Eastern Time Investor Conference Call to be held 9:00 a.m. Eastern Time
Rochester Hills, Michigan, June 18, 2020 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provider...
Investor Presentation to be held 1:00 p.m. Eastern Time Investor Presentation to be held 1:00 p.m. Eastern Time
InfuSystem Holdings Inc. (INFU) CEO Rich DiIorio on Q1 2020 Results - Earnings Call Transcript
The company is still on pace to join the Russell2000, which should provide a huge tailwind to a thinly-traded name.
InfuSystem Holdings, Inc. (INFU) CEO Rich DiIorio on Q4 2019 Results - Earnings Call Transcript
ROCHESTER HILLS, Michigan, March 12, 2020 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provide...
ROCHESTER HILLS, MICHIGAN, Feb. 11, 2020 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider,...
ROCHESTER HILLS, MICHIGAN, Feb. 07, 2020 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national healthcare service provider ...
InfuSystem's Operating Leverage Reaches Inflection Point
InfuSystem Holdings Inc.'s (INFU) CEO Rich DiIorio on Q3 2019 Results - Earnings Call Transcript
MADISON HEIGHTS, MICHIGAN, Oct. 02, 2019 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American LLC: INFU) (“InfuSystem” or the “Company”), a leading national provider of infusion pump...
MADISON HEIGHTS, MICHIGAN, Sept. 30, 2019 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national provider of infusion pumps a...
The company is on a growth path due to increased incidence of colorectal cancer.
Providing infusion pump repair service in North America for Sapphire infusion system Providing infusion pump repair service in North America for Sapphire infusion system
InfuSystem Holdings, Inc. (INFU) CEO Richard DiIorio on Q2 2019 Results - Earnings Call Transcript
InfuSystem Holdings Inc. (INFU) CEO Rich Dilorio on Q1 2019 Results - Earnings Call Transcript
About INFU
InfuSystem Holdings, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps; and provides biomedical re... [Read more...]
| Industry Medical Instruments & Supplies | Founded 2005 |
| CEO Richard A. DiIorio | Employees 261 |
| Stock Exchange NYSEAMERICAN | Ticker Symbol INFU |
Analyst Forecasts
According to 3 analysts, the average rating for INFU stock is "Strong Buy." The 12-month stock price forecast is 25.67, which is an increase of 50.47% from the latest price.